Researchers are a step closer to revolutionizing how doctors use radiotherapy to treat patients with muscle-invasive bladder ...

Lara Stevens says endometriosis is like the cancer she had as a child, with the potential to spread and damage multiple ...

EQS-News: Eckert & Ziegler SE / Key word (s): Contract/Alliance Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply 08.10.2024 / 08:00 CET/CEST The issuer is solely responsible ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond ...

WILMETTE, IL, USA I October 07, 2024 I Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative ...

The Francis Crick Institute and the Royal Marsden Foundation Trust are spearheading the MANIFEST project with £21.9 million in government and industry funding.

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest. It can help providers decide which ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced the appointment of Suyasha Gupta as Senior ...

Finding a financial advisor doesn't have to be hard. SmartAsset's free tool matches you with up to three fiduciary financial advisors that serve your area in minutes. Each advisor has been vetted by ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive ...